CASE

Model: DW-25L262 biomedical freezer The NIHR Sheffield Clinical Research Facility - providing cutting-edge research including potentially life-saving research into diabetes、 heart、respiratory、 bone and kidney diseases.  Between 1,500 and 2,000 new patients take part in Clinical Research Facility trials each year.

Sample project has been set in the international renowned university showing a strong demonstration effect which set a excellent example for Haier Smart Frequency ULT freezer promotion.

At the University of Sydney in Australia，40 Haier water-cooled ULT freezers are being installed. 

6 water-cooled ultra-low temperature refrigerators, DW-86L959W, from Haier, are loved by local researchers for their high capacity, low energy consumption and high performance.

Q2 Solutions, the world’s second largest clinical laboratory services provider.

The Department of Materials, Imperial College London, recently purchased a Haier Biomedical ULT freezer after issues with delivery times from another vendor.

Haier Biomedical’s products now located at top research universities in the U.S. to assist in the development of anti-pandemic research and are trusted by U.S. government agencies as a long-term partner.

To alleviate the blood shortage in Cameroon and improve the quality of local healthcare, the World Health Organization, in collaboration with ISDB Bank, has chosen Haier Biomedical to fund and purchase Haier Biomedical’s Blood Refrigerator HXC-106 and Haier Biomedical’s Plasma Freezer DW40-W100, a total of 196 units of Haier Biomedical products to help build the national blood transfusion centre and 4 regional blood transfusion centres in Cameroon. 

COVAX, known as the COVID-19 Vaccine Implementation Program, is co-led by the Coalition for Epidemic Prevention and Innovation (CEPI), the Vaccine Alliance (Gavi) and the World Health Organization (WHO) to ensure equitable access to the COVID-19 vaccine for all participating countries and economies. 

According to an announcement by the South African Government, vaccination in South Africa will take a three-phase approach that begins with the most vulnerable in the population.